Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04398147 |
|---|---|
| Brief Title: | Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada |
| First Submitted : | May 18, 2020 |
| First Submitted that Met QC Criteria : | May 18, 2020 |
| First Posted : | May 21, 2020 |
| Last Update Submitted that Met QC Criteria : | June 30, 2020 |
| Last Update Posted : | July 2, 2020 |